[
    [
        {
            "time": "",
            "orginal_text": "谁的金戈？首个国产伟哥药股东爆利益纠纷 诉讼纠纷",
            "features": {
                "keywords": [
                    "金戈",
                    "国产伟哥",
                    "股东",
                    "利益纠纷",
                    "诉讼"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "谁的金戈？首个国产伟哥药股东爆利益纠纷 诉讼纠纷",
            "scores": {
                "News_content": "谁的金戈？首个国产伟哥药股东爆利益纠纷 诉讼纠纷",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "国产“伟哥”陷“罗生门”：金戈毛率高达87% 欺诈造假",
            "features": {
                "keywords": [
                    "国产伟哥",
                    "金戈",
                    "毛利润率",
                    "欺诈",
                    "造假"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "国产“伟哥”陷“罗生门”：金戈毛率高达87% 欺诈造假",
            "scores": {
                "News_content": "国产“伟哥”陷“罗生门”：金戈毛率高达87% 欺诈造假",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "“国产伟哥”到底属于谁？康业元举报白云山造假罗生门背后 诉讼纠纷",
            "features": {
                "keywords": [
                    "国产伟哥",
                    "康业元",
                    "白云山",
                    "造假",
                    "罗生门",
                    "诉讼纠纷"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "“国产伟哥”到底属于谁？康业元举报白云山造假罗生门背后 诉讼纠纷",
            "scores": {
                "News_content": "“国产伟哥”到底属于谁？康业元举报白云山造假罗生门背后 诉讼纠纷",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "金戈“罗生门”：抗ED市场变局触发多方博弈",
            "features": {
                "keywords": [
                    "金戈",
                    "罗生门",
                    "抗ED市场",
                    "多方博弈"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "金戈“罗生门”：抗ED市场变局触发多方博弈",
            "scores": {
                "News_content": "金戈“罗生门”：抗ED市场变局触发多方博弈",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "“伟哥”代理商的 冰火两重天",
            "features": {
                "keywords": [
                    "伟哥",
                    "代理商",
                    "冰火两重天"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "“伟哥”代理商的 冰火两重天",
            "scores": {
                "News_content": "“伟哥”代理商的 冰火两重天",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "“金戈”产权、收益归谁？白云山：双方股东未达成一致意见",
            "features": {
                "keywords": [
                    "金戈",
                    "产权",
                    "收益",
                    "白云山",
                    "股东",
                    "未达成一致"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "“金戈”产权、收益归谁？白云山：双方股东未达成一致意见",
            "scores": {
                "News_content": "“金戈”产权、收益归谁？白云山：双方股东未达成一致意见",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]